Chengdu Easton Biopharmaceuticals Co., Ltd.

¥41.85As of Sun 8 Nov 2026, 12:00 UTC
SSE:688513Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR 4.03%
Div yield 1.17%
ROE 7.77%
Biotechnology
Beta (5Y) 0.12
PE TTM 26.50
TSR TTM (28.89%)
Mkt cap ¥7.245B
ROIC 9.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥49
18.18%
(33.29%)
Hold 9|7|1|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.87
0.90
0.97
0.92
26.08%
19.55%
24.15%
5.96%
Revenue¥M
434.2
436.1
448.9
440.5
6.35%
1.63%
1.55%
1.35%
Peers (US$1.086B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.416
0.749
0.475
EBIT/Intx
0.337
0.262
0.252
Own earn%
3.21
(2.71)
(6.11)
Sh yield%
38.19
34.55
33.78
Owners
Insiders/Inst%
4.02
59.10
Short interest%
0.90
SBC / revenue%
1.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
20–27
$1 testx
—
Incr. ROIC%
6